JBL X: Nov. 2007
10th Annual John B. Little Symposium
“Cancer Stem Cells, Radiotherapy, and Modulation by Cellular Responses”
November 2-3, 2007
Friday, November 2, 2007
|
John B. Little Award Lecture given by Allan Balmain, Ph.D. Barbara Bass Bakar Endowed Chair in Cancer Genetics University of California, San Francisco “Genetic networks and control of cancer susceptibility” |
|
Charlotte Kuperwasser, Ph.D. Assistant Professor of Anatomy and Cellular Biology Tufts University School of Medicine “The contribution and role of the stromal microenvironment on breast cancer stem cells” |
|
Haifan Lin, Ph.D. Director, Yale Stem Cell Center; Professor of Cell Biology Yale University “Stem cells, small RNAs, and self-renewal” |
|
Paul Russell, Ph.D. Professor The Scripps Research Institute “Cell cycle governance of double-strand break repair” |
|
Pier Paolo Pandolfi, M.D., Ph.D., Professor; Associate Director, Beth Israel Deaconess Cancer Center; Chief, Division of Genetics Beth Israel Deaconess Medical Center “Pro-senescence therapy for cancer” |
|
Frank McKeon, Ph.D. Professor of Cell Biology Harvard Medical School “My brother thinks he’s a chicken: p63 as guardian of the female germline” |
|
Norman Sharpless, M.D. Assistant Professor, Lineberger Comprehensive Cancer Center University of North Carolina “Ink4α/Arf, senescence and stem cells” |
|
Scott Armstrong, M.D., Ph.D. Assistant Professor of Pediatrics Children’s Hospital, Harvard Medical School “Cellular origins of leukemia stem cells” |
|
Alea Mills, Ph.D. Associate Professor Cold Spring Harbor Laboratory “From chromosome engineering to chromatin remodeler: CHD5 is a tumor suppressor at human 1p36 |
|
Stewart Shuman, M.D., Ph.D. Memorial Sloan-Kettering Cancer Center “RNA repair” |
|
Michael Yaffe, Ph.D., M.D. Associate Professor of Biology Massachusetts Institute of Technology “A systems biology approach to DNA damage signaling” |
|
Kornelia Polyak, M.D., Ph.D. Associate Professor of Medicine Dana-Farber Cancer Institute, Harvard Medical School “Molecular definition of breast tumor heterogeneity” |